Schering-Plough ends securities suit tied to production issues

03/15/2009 | CNNMoney

Schering-Plough agreed to pay $165 million to settle a securities class-action lawsuit alleging that the drugmaker concealed information about manufacturing problems that led to the delayed FDA approval of allergy drug Clarinex. The company continues to deny any wrongdoing, saying the settlement was reached to avoid further litigation.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN